Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Intraparotid injection of bupivacaine with dexamethasone after partial parotidectomy

Official title: Evaluation of the Clinical Tolerance of an Intraparotid Injection of Bupivacaine, Combined With Dexamethasone, After Parotidectomy for Benign Tumor - A Single-center Prospective Cohort Study.

Run by Centre Hospitalier Universitaire de Nīmes · NCT07812259 · Data updated 2026-11-12

This early-phase study tests whether a single intraparotid injection of bupivacaine with dexamethasone is safe and tolerable after partial parotidectomy for a benign tumor.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorCentre Hospitalier Universitaire de Nīmes
Academic / other
Locations1 site (Nîmes)
StatusRecruiting
StartedMay 18, 2026
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedSeptember 10, 2026
Trial IDNCT07812259 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing partial parotidectomy for benign parotid tumors who can provide informed consent and have appropriate health insurance.

Probably not a fit

Patients with contraindications to local amino-amide anesthetics, excessive comorbidities, or inability to consent may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early phase1 trial investigates the safety and tolerability of a single intraparotid injection of bupivacaine combined with dexamethasone administered after partial parotidectomy for benign parotid tumors. The approach targets reducing postoperative saliva-related complications by providing prolonged local anesthesia and anti-inflammatory effects. Participants are adults with a surgical indication for partial parotidectomy who consent to participate and meet eligibility criteria. The study design is interventional; specific endpoints and procedures are described in the protocol. No comparator is stated at this phase, and results will inform feasibility and potential for larger studies.

Why it matters

Potential benefit: If successful, the approach could reduce postoperative salivary complications and improve comfort after partial parotidectomy.

How similar studies have gone: Previous similar approaches in this area are limited; this trial explores feasibility and safety in a novel single-injection strategy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Validated surgical indication for partial parotidectomy for parotid tumor.
* The patient must have given their free and informed consent and signed the consent form
* The patient must be a member or beneficiary of a health insurance plan

Exclusion Criteria:

* The subject is in a period of exclusion determined by a previous study
* The patient is under safeguard of justice or state guardianship
* History of allergic reaction to amino-amide-type local anesthetics.
* Severe neurological history (epilepsy, peripheral neuropathies).
* High-risk cardiovascular history (severe hypertension, arrhythmias, complete or incomplete heart block, heart failure, coronary artery disease, treatment with type 2 antiarrhythmic drugs).
* Severe liver or kidney disease (severe liver failure or severe kidney failure).
* Acidosis, sepsis.
* Pregnant or breastfeeding patient.
* Patient unable to give informed consent.
* Patient for whom it is impossible to provide informed consent.

Where it's running

  • Centre Hospitalier de Nimes
    Nîmes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.